EV Biologics, Inc. (YECO)
OTCMKTS
· Delayed Price · Currency is USD
0.295
0.00 (0.00%)
At close: Sep 17, 2024
EV Biologics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2017 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | 2013 - 2012 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '17 Dec 31, 2017 | Dec '17 Dec 31, 2017 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 | Jun '15 Jun 30, 2015 | Jun '14 Jun 30, 2014 | 2013 - 2012 |
| Net Income | - | - | -7.43 | -53.19 | 8.68 | 10.69 | Upgrade
|
| Depreciation & Amortization | - | - | 0.69 | 2.22 | 1.75 | 1.39 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 1.91 | 52.69 | - | - | Upgrade
|
| Stock-Based Compensation | - | - | 0.16 | 0.53 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 2 | 4.07 | - | -0.13 | Upgrade
|
| Other Operating Activities | - | - | 0.16 | 2.54 | -0.33 | -0.07 | Upgrade
|
| Change in Accounts Receivable | - | - | -1.35 | -1.12 | -4.09 | -1.08 | Upgrade
|
| Change in Inventory | - | - | 0.19 | -0.24 | 0.11 | -0.12 | Upgrade
|
| Change in Accounts Payable | - | - | 0.62 | 0.13 | -0.11 | 0.29 | Upgrade
|
| Change in Unearned Revenue | - | - | 1.92 | 2.66 | -0.4 | 0.38 | Upgrade
|
| Change in Income Taxes | - | - | -0.15 | 0.5 | -0.02 | 0.14 | Upgrade
|
| Change in Other Net Operating Assets | - | - | 2.82 | 2.5 | 0.61 | 0.62 | Upgrade
|
| Operating Cash Flow | - | - | 1.55 | 13.28 | 6.2 | 12.11 | Upgrade
|
| Operating Cash Flow Growth | - | - | -88.33% | 114.10% | -48.81% | 6.64% | Upgrade
|
| Capital Expenditures | - | - | -1.93 | -36.62 | -2.02 | -0.84 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.02 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0 | -0.01 | -0.11 | Upgrade
|
| Other Investing Activities | - | - | - | - | 0.03 | 2.6 | Upgrade
|
| Investing Cash Flow | - | - | -1.93 | -36.6 | -2 | 1.65 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 5.61 | 4.48 | 7.1 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 1.86 | Upgrade
|
| Total Debt Issued | - | - | - | 5.61 | 4.48 | 8.96 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.45 | -5.91 | -10.84 | -8.53 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.59 | -1.23 | -0.25 | Upgrade
|
| Total Debt Repaid | - | - | -0.45 | -6.5 | -12.07 | -8.78 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -0.45 | -0.89 | -7.59 | 0.18 | Upgrade
|
| Issuance of Common Stock | - | - | - | 14.06 | - | - | Upgrade
|
| Other Financing Activities | - | - | - | -2.55 | - | - | Upgrade
|
| Financing Cash Flow | - | - | -0.45 | 10.62 | -7.59 | 0.18 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | -0.09 | -1.04 | 0.13 | -0 | Upgrade
|
| Net Cash Flow | - | - | -0.92 | -13.74 | -3.26 | 13.94 | Upgrade
|
| Free Cash Flow | - | - | -0.38 | -23.34 | 4.19 | 11.27 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -62.87% | - | Upgrade
|
| Free Cash Flow Margin | - | - | -3.99% | -54.74% | 9.05% | 25.35% | Upgrade
|
| Free Cash Flow Per Share | - | - | -0.16 | -9.79 | 2.62 | 7.04 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.2 | 1.07 | 1.22 | Upgrade
|
| Cash Income Tax Paid | - | - | 0.55 | 2.6 | 3.2 | 3.18 | Upgrade
|
| Levered Free Cash Flow | - | - | 1.15 | -32.1 | 15.17 | 11.8 | Upgrade
|
| Unlevered Free Cash Flow | - | - | 1.56 | -31.46 | 15.98 | 12.54 | Upgrade
|
| Change in Net Working Capital | - | - | -5.09 | -0.26 | -8.21 | -2.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.